Basilea Pharmaceutica 2020 Investment Conference Presentation

Basilea Pharmaceutica is a commercial-stage biotech company focused on oncology and infectious diseases, with two revenue-generating hospital anti-infective brands (Cresemba and Zevtera) and two clinical oncology candidates in development. Based in Basel, Switzerland and listed on SIX Swiss Stock Exchange, the company demonstrates sustainable growth potential through its commercialized portfolio and innovative pipeline.